Project 3: ACHIEVE- CHD
ACHIEVE GREATER: Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region
University Hospitals Cleveland Medical Center
500 participants
Aug 15, 2022
INTERVENTIONAL
Conditions
Summary
This project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region) Center (IRB 100221MP2A), the purpose of which is to reduce cardiometabolic health disparities and downstream Black-White lifespan inequality in two cities: Detroit, Michigan, and Cleveland, Ohio. The ACHIEVE GREATER Center will involve three separate but related projects that aim to mitigate health disparities in risk factor control for three chronic conditions, hypertension (HTN, Project 1), heart failure (HF, Project 2) and coronary heart disease (CHD, Project 3), which drive downstream lifespan inequality. All three projects will involve the use of Community Health Workers (CHWs) to deliver an evidence-based practice intervention program called PAL2. All three projects will also utilize the PAL2 Implementation Intervention (PAL2-II), which is a set of structured training and evaluation strategies designed to optimize CHW competence and adherence (i.e., fidelity) to the PAL2 intervention program. The present study is Project 3 of the ACHIEVE GREATER Center.
Eligibility
Inclusion Criteria13
- 40 to 75 years of age
- Self-identified as Black or African American
- Residence in the Cleveland Metro Area
- Must have at least two of the following risk factors identified at a UH health fair screenings, with one risk factor being with SBP, A1c, or LDL:
- BMI≥30 mg/dL
- History of smoking
- Elevated blood pressure defined as SBP>140 or DBP>80 mmHg
- HbA1c≥5.7%
- LDL≥130
- Able to complete a coronary artery calcium score test (CAC)
- Willing and able to consent
- Willing to have a UH provider and UH care
- Currently insured for standard of care procedures
Exclusion Criteria5
- Established documented cardiovascular disease (coronary artery disease, peripheral artery disease, myocardial infarction, stroke).
- Systolic blood pressure ≥ 180 mmHg or diastolic blood pressure ≥ 110 mmHg
- Lung disease requiring supplemental oxygen therapy
- Individuals receiving treatment for cancer related disease
- Pregnant or nursing mothers
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Low CVD risk participants (CAC \< 100) will be followed by their primary care provider accompanied by monthly contact with community health workers provided by ACHIEVE Greater who will screen participants for social determinants of health and implement the PAL2. PAL2 is defined as a community health worked based intervention to mitigate psychosocial and health equity barriers to optimize health promotion coupled with high blood pressure and lifestyle disease state education.
High CVD risk participants (CAC ≥ 100) will be followed by specialists in the Center for Integrated and Novel Approaches in Vascular-Metabolic Disease (CINEMA) at UHCMC. While they too will be assessed, by the CHW for SDOH and a plan developed to address them, this plan will be addressed by the usual resources available in the CINEMA clinic.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05918380